Clinical trial NCT06082973 - References

Type 1 Diabetes — Dual-hormone Artificial Pancreas Versus Single-hormone Under Exercise and a Meal Challenge

Citation(s)

•   Brazeau AS, Rabasa-Lhoret R, Strychar I, Mircescu H
  Barriers to physical activity among patients with type 1 diabetes. Diabetes Care. 2008 Nov;31(11):2108-9. doi: 10.2337/dc08-0720. Epub 2008 Aug 8.
•   Eckstein ML, Weilguni B, Tauschmann M, Zimmer RT, Aziz F, Sourij H, Moser O
  Time in Range for Closed-Loop Systems versus Standard of Care during Physical Exercise in People with Type 1 Diabetes: A Systematic Review and Meta-Analysis. J Clin Med. 2021 May 31;10(11):2445. doi: 10.3390/jcm10112445.
•   Haidar A
  Insulin-and-Glucagon Artificial Pancreas Versus Insulin-Alone Artificial Pancreas: A Short Review. Diabetes Spectr. 2019 Aug;32(3):215-221. doi: 10.2337/ds18-0097.
•   Lakshman R, Boughton C, Hovorka R
  The changing landscape of automated insulin delivery in the management of type 1 diabetes. Endocr Connect. 2023 Jul 31;12(8):e230132. doi: 10.1530/EC-23-0132.
•   Laugesen C, Ranjan AG, Schmidt S, Norgaard K
  Low-Dose Dasiglucagon Versus Oral Glucose for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes: A Phase 2, Randomized, Three-Arm Crossover Study. Diabetes Care. 2022 Jun 2;45(6):1391-1399. doi: 10.2337/dc21-2304.
•   Paldus B, Morrison D, Lee M, Zaharieva DP, Riddell MC, O'Neal DN
  Strengths and Challenges of Closed-Loop Insulin Delivery During Exercise in People With Type 1 Diabetes: Potential Future Directions. J Diabetes Sci Technol. 2023 Jul;17(4):1077-1084. doi: 10.1177/19322968221088327. Epub 2022 Apr 24.
•   Taleb N, Emami A, Suppere C, Messier V, Legault L, Ladouceur M, Chiasson JL, Haidar A, Rabasa-Lhoret R
  Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: randomised controlled crossover trial. Diabetologia. 2016 Dec;59(12):2561-2571. doi: 10.1007/s00125-016-4107-0. Epub 2016 Oct 4.
•   Wilson LM, Jacobs PG, Castle JR
  Role of Glucagon in Automated Insulin Delivery. Endocrinol Metab Clin North Am. 2020 Mar;49(1):179-202. doi: 10.1016/j.ecl.2019.10.008. Epub 2019 Dec 10.
•   Zaharieva DP, Morrison D, Paldus B, Lal RA, Buckingham BA, O'Neal DN
  Practical Aspects and Exercise Safety Benefits of Automated Insulin Delivery Systems in Type 1 Diabetes. Diabetes Spectr. 2023 May;36(2):127-136. doi: 10.2337/dsi22-0018. Epub 2023 May 15.

Evaluation of Dual-hormone Artificial Pancreas With Closed-loop Glucose Control Versus Single-hormone With Carbohydrate Recommendations Under Unannounced Exercise and Meal Challenge in Adults With Type 1 Diabetes.

Details for clinical trial NCT06082973